Postmortem analysis of quetiapine and pregabalin in human bone.

Abstract In this study quetiapine and pregabalin were analyzed in human bones. A method previously developed for the determination of antidepressants in human bone was tested for the analysis of these two substances. Bones were pulverized and subjected to the extraction protocol, and after undergoing solid-phase extraction, samples were analyzed using gas chromatography–mass spectrometry. The assay was validated in the range 0.3-500 ng/mg, mean analytical recovery was 76.9 % for quetiapine and 90.9 % for pregabalin, matrix effect was 83 % for quetiapine and 91 % for pregabalin and process efficiency was 63.8 % for quetiapine and 82.7 % for pregabalin. The intra- and inter-day precision was below 3 % in all cases and the intra- and inter-assay accuracy values were in almost all cases better than 12%. The validated method was then applied to bone samples from forensic cases. Drugs were detected in bone in 2 of the 3 blood positive cases. The approximate concentrations in bone were 40 ng/mg for pregabalin and 7 ng/mg for quetiapine. To our knowledge, this is the first time these substances were detected in bones. With this study the number of substances with a validated protocol to be used in human bones in case of necessity is expanded.